
Glimiwin MV2 Tablet
Marketer
Docwin Healthcare
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glimiwin MV2 Tablet
Diabetace Combiflex tablets are classified as antidiabetic medications, specifically a combination therapy for managing type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabetace Combiflex should be administered with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can elevate glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan incorporating a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most common adverse effect. Learn to recognize its symptoms – sweating, dizziness, headache, and trembling – and know how to treat it. Consistent meals and readily available fast-acting glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption should be limited due to increased hypoglycemia risk. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their doctor before commencing treatment. Pregnant or lactating women require physician consultation. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are usually recommended.
Uses of Glimiwin MV2 Tablet
Managing type 2 diabetes
Major Benefits of Glimiwin MV2 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Glimiwin MV2 Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication on an empty stomach.
Common Side effects of Glimiwin MV2 Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimiwin MV2 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimiwin MV2 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication on an empty stomach.
How Glimiwin MV2 Tablet works:
The formulation Glimiwin MV2 Tablet comprises a triple-action antidiabetic medication.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glimiwin MV2 Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimiwin MV2 Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing this medication. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimiwin MV2 Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.
KidneyUNSAFE
The use of Glimiwin MV2 Tablets is contraindicated in patients with kidney disease; it poses a significant risk and should be avoided. Patients with severe kidney impairment should especially refrain from using this medication. Medical advice is essential.
LiverCAUTION
Patients with liver impairment should use Glimiwin MV2 Tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For individuals with mild to moderate liver disease, Glimiwin MV2 Tablets are typically initiated at a low dose; however, their use is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Glimiwin MV2 Tablet :
Should you forget a Glimiwin MV2 Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimiwin MV2 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
